What is your approach to de-escalation of asthma inhaler therapy in the setting of negative bronchoprovocation testing when patients are averse to deprescribing?

I discuss the reason we are doing the bronchoprovacation test and what the results would mean. This makes it easier for patients to de-escalate therapy and seek an alternative diagnosis for their symptoms.